MedPath

Cancer Center of Irvine

🇺🇸United States
Ownership
-
Established
2011-01-01
Employees
-
Market Cap
-
Website
http://www.crcl.fr/

Clinical Trials

4

Active:0
Completed:3

Trial Phases

2 Phases

Phase 1:1
Phase 4:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 4
2 (66.7%)
Phase 1
1 (33.3%)

Defining Recurrent Disease With Axumin™

Conditions
Prostate Adenocarcinoma
Prostate Cancer
Interventions
Radiation: Salvage Radiation, Axumin
First Posted Date
2019-06-25
Last Posted Date
2019-06-25
Lead Sponsor
Cancer Center of Irvine
Target Recruit Count
20
Registration Number
NCT03996993
Locations
🇺🇸

Kenneth Tokita, Irvine, California, United States

Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate Cancer

Phase 1
Completed
Conditions
Prostate Cancer
First Posted Date
2009-04-16
Last Posted Date
2013-02-15
Lead Sponsor
Cancer Center of Irvine
Target Recruit Count
10
Registration Number
NCT00882232
Locations
🇺🇸

Cancer Center of Irvine, Irvine, California, United States

Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-risk" Breast Cancer Patients

Phase 4
Completed
Conditions
Breast Cancer
First Posted Date
2009-04-16
Last Posted Date
2018-01-25
Lead Sponsor
Cancer Center of Irvine
Target Recruit Count
30
Registration Number
NCT00882596
Locations
🇺🇸

Cancer Center of Irvine, Irvine, California, United States

Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients

Phase 4
Completed
Conditions
Breast Cancer
First Posted Date
2009-04-16
Last Posted Date
2018-01-25
Lead Sponsor
Cancer Center of Irvine
Target Recruit Count
13
Registration Number
NCT00882089
Locations
🇺🇸

Cancer Center of Irvine, Irvine, California, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.